Inflammatory response time course, HUVEC (Wada et al., 2009)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MEIS2
|
ENSG00000134138.15 | Meis homeobox 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MEIS2 | hg19_v2_chr15_-_37391507_37391604 | -0.17 | 4.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_+_113344755 | 1.44 |
ENST00000550883.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr8_-_13372253 | 1.42 |
ENST00000316609.5
|
DLC1
|
deleted in liver cancer 1 |
chr1_+_79115503 | 1.29 |
ENST00000370747.4
ENST00000438486.1 ENST00000545124.1 |
IFI44
|
interferon-induced protein 44 |
chr1_+_84873913 | 0.92 |
ENST00000370662.3
|
DNASE2B
|
deoxyribonuclease II beta |
chr6_-_112408661 | 0.88 |
ENST00000368662.5
|
TUBE1
|
tubulin, epsilon 1 |
chr21_-_31744557 | 0.84 |
ENST00000399889.2
|
KRTAP13-2
|
keratin associated protein 13-2 |
chr12_+_113344582 | 0.84 |
ENST00000202917.5
ENST00000445409.2 ENST00000452357.2 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr12_-_30887948 | 0.83 |
ENST00000433722.2
|
CAPRIN2
|
caprin family member 2 |
chr17_-_58469591 | 0.74 |
ENST00000589335.1
|
USP32
|
ubiquitin specific peptidase 32 |
chr18_+_3449330 | 0.67 |
ENST00000549253.1
|
TGIF1
|
TGFB-induced factor homeobox 1 |
chr22_-_36018569 | 0.62 |
ENST00000419229.1
ENST00000406324.1 |
MB
|
myoglobin |
chr5_-_19988339 | 0.62 |
ENST00000382275.1
|
CDH18
|
cadherin 18, type 2 |
chr14_+_24540731 | 0.61 |
ENST00000558859.1
ENST00000559197.1 ENST00000560828.1 ENST00000216775.2 ENST00000560884.1 |
CPNE6
|
copine VI (neuronal) |
chr6_-_133084580 | 0.60 |
ENST00000525270.1
ENST00000530536.1 ENST00000524919.1 |
VNN2
|
vanin 2 |
chr2_+_241564655 | 0.57 |
ENST00000407714.1
|
GPR35
|
G protein-coupled receptor 35 |
chr3_+_118866222 | 0.57 |
ENST00000490594.1
|
RP11-484M3.5
|
Uncharacterized protein |
chr12_+_101188718 | 0.56 |
ENST00000299222.9
ENST00000392977.3 |
ANO4
|
anoctamin 4 |
chr17_-_29648761 | 0.55 |
ENST00000247270.3
ENST00000462804.2 |
EVI2A
|
ecotropic viral integration site 2A |
chr1_+_144989309 | 0.55 |
ENST00000596396.1
|
AL590452.1
|
Uncharacterized protein |
chr5_-_20575959 | 0.54 |
ENST00000507958.1
|
CDH18
|
cadherin 18, type 2 |
chr1_-_100598444 | 0.53 |
ENST00000535161.1
ENST00000287482.5 |
SASS6
|
spindle assembly 6 homolog (C. elegans) |
chr12_+_15125954 | 0.53 |
ENST00000266395.2
|
PDE6H
|
phosphodiesterase 6H, cGMP-specific, cone, gamma |
chr2_-_202562774 | 0.53 |
ENST00000396886.3
ENST00000409143.1 |
MPP4
|
membrane protein, palmitoylated 4 (MAGUK p55 subfamily member 4) |
chr12_+_8662057 | 0.52 |
ENST00000382064.2
|
CLEC4D
|
C-type lectin domain family 4, member D |
chr1_-_76398077 | 0.51 |
ENST00000284142.6
|
ASB17
|
ankyrin repeat and SOCS box containing 17 |
chr1_-_238054094 | 0.51 |
ENST00000366570.4
|
ZP4
|
zona pellucida glycoprotein 4 |
chr6_-_28220002 | 0.51 |
ENST00000377294.2
|
ZKSCAN4
|
zinc finger with KRAB and SCAN domains 4 |
chr22_+_31518938 | 0.50 |
ENST00000412985.1
ENST00000331075.5 ENST00000412277.2 ENST00000420017.1 ENST00000400294.2 ENST00000405300.1 ENST00000404390.3 |
INPP5J
|
inositol polyphosphate-5-phosphatase J |
chr4_-_101111615 | 0.50 |
ENST00000273990.2
|
DDIT4L
|
DNA-damage-inducible transcript 4-like |
chr17_-_34207295 | 0.50 |
ENST00000463941.1
ENST00000293272.3 |
CCL5
|
chemokine (C-C motif) ligand 5 |
chr4_+_90033968 | 0.49 |
ENST00000317005.2
|
TIGD2
|
tigger transposable element derived 2 |
chr20_-_55100981 | 0.49 |
ENST00000243913.4
|
GCNT7
|
glucosaminyl (N-acetyl) transferase family member 7 |
chr13_-_33780133 | 0.48 |
ENST00000399365.3
|
STARD13
|
StAR-related lipid transfer (START) domain containing 13 |
chr12_+_55248289 | 0.48 |
ENST00000308796.6
|
MUCL1
|
mucin-like 1 |
chr4_+_175204818 | 0.47 |
ENST00000503780.1
|
CEP44
|
centrosomal protein 44kDa |
chr17_+_41158742 | 0.47 |
ENST00000415816.2
ENST00000438323.2 |
IFI35
|
interferon-induced protein 35 |
chr19_+_39687596 | 0.47 |
ENST00000339852.4
|
NCCRP1
|
non-specific cytotoxic cell receptor protein 1 homolog (zebrafish) |
chr13_-_67802549 | 0.47 |
ENST00000328454.5
ENST00000377865.2 |
PCDH9
|
protocadherin 9 |
chr4_-_83931862 | 0.46 |
ENST00000506560.1
ENST00000442461.2 ENST00000446851.2 ENST00000340417.3 |
LIN54
|
lin-54 homolog (C. elegans) |
chr20_-_35580240 | 0.46 |
ENST00000262878.4
|
SAMHD1
|
SAM domain and HD domain 1 |
chr14_-_95942173 | 0.45 |
ENST00000334258.5
ENST00000557275.1 ENST00000553340.1 |
SYNE3
|
spectrin repeat containing, nuclear envelope family member 3 |
chr6_-_3195981 | 0.45 |
ENST00000425384.2
ENST00000435043.2 |
RP1-40E16.9
|
RP1-40E16.9 |
chr2_-_202563414 | 0.44 |
ENST00000409474.3
ENST00000315506.7 ENST00000359962.5 |
MPP4
|
membrane protein, palmitoylated 4 (MAGUK p55 subfamily member 4) |
chr14_+_24630465 | 0.44 |
ENST00000557894.1
ENST00000559284.1 ENST00000560275.1 |
IRF9
|
interferon regulatory factor 9 |
chr11_-_19262486 | 0.44 |
ENST00000250024.4
|
E2F8
|
E2F transcription factor 8 |
chr9_+_109694914 | 0.44 |
ENST00000542028.1
|
ZNF462
|
zinc finger protein 462 |
chr19_+_13261216 | 0.43 |
ENST00000587885.1
ENST00000292433.3 |
IER2
|
immediate early response 2 |
chr11_-_27723158 | 0.43 |
ENST00000395980.2
|
BDNF
|
brain-derived neurotrophic factor |
chr8_-_57123815 | 0.43 |
ENST00000316981.3
ENST00000423799.2 ENST00000429357.2 |
PLAG1
|
pleiomorphic adenoma gene 1 |
chr3_+_169629354 | 0.43 |
ENST00000428432.2
ENST00000335556.3 |
SAMD7
|
sterile alpha motif domain containing 7 |
chr11_-_5173599 | 0.42 |
ENST00000328942.1
|
OR52A1
|
olfactory receptor, family 52, subfamily A, member 1 |
chr1_+_172422026 | 0.42 |
ENST00000367725.4
|
C1orf105
|
chromosome 1 open reading frame 105 |
chr4_+_113218497 | 0.42 |
ENST00000458497.1
ENST00000177648.9 ENST00000504176.2 |
ALPK1
|
alpha-kinase 1 |
chr19_-_12662314 | 0.42 |
ENST00000339282.7
ENST00000596193.1 |
ZNF564
|
zinc finger protein 564 |
chr2_+_1418154 | 0.41 |
ENST00000423320.1
ENST00000382198.1 |
TPO
|
thyroid peroxidase |
chr2_+_1488435 | 0.41 |
ENST00000446278.1
ENST00000469607.1 |
TPO
|
thyroid peroxidase |
chr10_-_131762105 | 0.41 |
ENST00000368648.3
ENST00000355311.5 |
EBF3
|
early B-cell factor 3 |
chr7_-_27219849 | 0.41 |
ENST00000396344.4
|
HOXA10
|
homeobox A10 |
chr4_-_149365827 | 0.41 |
ENST00000344721.4
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2 |
chr3_-_12587055 | 0.40 |
ENST00000564146.3
|
C3orf83
|
chromosome 3 open reading frame 83 |
chr1_+_104068562 | 0.40 |
ENST00000423855.2
|
RNPC3
|
RNA-binding region (RNP1, RRM) containing 3 |
chr21_+_40823753 | 0.40 |
ENST00000333634.4
|
SH3BGR
|
SH3 domain binding glutamic acid-rich protein |
chr14_+_24540046 | 0.40 |
ENST00000397016.2
ENST00000537691.1 ENST00000560356.1 ENST00000558450.1 |
CPNE6
|
copine VI (neuronal) |
chr15_+_42696992 | 0.40 |
ENST00000561817.1
|
CAPN3
|
calpain 3, (p94) |
chr4_-_123542224 | 0.40 |
ENST00000264497.3
|
IL21
|
interleukin 21 |
chr1_+_53662101 | 0.40 |
ENST00000371486.3
|
CPT2
|
carnitine palmitoyltransferase 2 |
chr2_-_69180012 | 0.39 |
ENST00000481498.1
|
GKN2
|
gastrokine 2 |
chr2_+_234959323 | 0.39 |
ENST00000373368.1
ENST00000168148.3 |
SPP2
|
secreted phosphoprotein 2, 24kDa |
chr19_-_49843539 | 0.39 |
ENST00000602554.1
ENST00000358234.4 |
CTC-301O7.4
|
CTC-301O7.4 |
chr5_-_176057365 | 0.39 |
ENST00000310112.3
|
SNCB
|
synuclein, beta |
chr11_-_51412448 | 0.39 |
ENST00000319760.6
|
OR4A5
|
olfactory receptor, family 4, subfamily A, member 5 |
chr1_-_15735925 | 0.39 |
ENST00000427824.1
|
RP3-467K16.4
|
RP3-467K16.4 |
chr1_-_182558374 | 0.39 |
ENST00000367559.3
ENST00000539397.1 |
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent) |
chr10_-_70287231 | 0.39 |
ENST00000609923.1
|
SLC25A16
|
solute carrier family 25 (mitochondrial carrier; Graves disease autoantigen), member 16 |
chrX_+_56259316 | 0.39 |
ENST00000468660.1
|
KLF8
|
Kruppel-like factor 8 |
chr10_+_54074033 | 0.39 |
ENST00000373970.3
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1 |
chr7_-_27169801 | 0.39 |
ENST00000511914.1
|
HOXA4
|
homeobox A4 |
chrX_-_118284542 | 0.38 |
ENST00000402510.2
|
KIAA1210
|
KIAA1210 |
chr6_-_13487784 | 0.38 |
ENST00000379287.3
|
GFOD1
|
glucose-fructose oxidoreductase domain containing 1 |
chr7_-_142139783 | 0.38 |
ENST00000390374.3
|
TRBV7-6
|
T cell receptor beta variable 7-6 |
chr11_-_124180733 | 0.38 |
ENST00000357821.2
|
OR8D1
|
olfactory receptor, family 8, subfamily D, member 1 |
chr2_-_89513402 | 0.38 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
chr15_+_92937058 | 0.38 |
ENST00000268164.3
|
ST8SIA2
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 |
chr12_+_82347498 | 0.38 |
ENST00000550506.1
|
RP11-362A1.1
|
RP11-362A1.1 |
chr5_+_81601166 | 0.38 |
ENST00000439350.1
|
ATP6AP1L
|
ATPase, H+ transporting, lysosomal accessory protein 1-like |
chr12_+_113416191 | 0.38 |
ENST00000342315.4
ENST00000392583.2 |
OAS2
|
2'-5'-oligoadenylate synthetase 2, 69/71kDa |
chr12_+_54378923 | 0.38 |
ENST00000303460.4
|
HOXC10
|
homeobox C10 |
chr13_+_50570019 | 0.37 |
ENST00000442421.1
|
TRIM13
|
tripartite motif containing 13 |
chrX_-_13956497 | 0.37 |
ENST00000398361.3
|
GPM6B
|
glycoprotein M6B |
chr17_+_45810594 | 0.37 |
ENST00000177694.1
|
TBX21
|
T-box 21 |
chr5_-_75008244 | 0.37 |
ENST00000510798.1
ENST00000446329.2 |
POC5
|
POC5 centriolar protein |
chr6_+_160327974 | 0.37 |
ENST00000252660.4
|
MAS1
|
MAS1 oncogene |
chr3_+_42897512 | 0.37 |
ENST00000493193.1
|
ACKR2
|
atypical chemokine receptor 2 |
chr2_-_165811756 | 0.37 |
ENST00000409662.1
|
SLC38A11
|
solute carrier family 38, member 11 |
chr2_-_202562716 | 0.37 |
ENST00000428900.2
|
MPP4
|
membrane protein, palmitoylated 4 (MAGUK p55 subfamily member 4) |
chr2_+_201390843 | 0.37 |
ENST00000357799.4
ENST00000409203.3 |
SGOL2
|
shugoshin-like 2 (S. pombe) |
chr6_+_53948328 | 0.37 |
ENST00000370876.2
|
MLIP
|
muscular LMNA-interacting protein |
chr13_-_103019744 | 0.37 |
ENST00000437115.2
|
FGF14-IT1
|
FGF14 intronic transcript 1 (non-protein coding) |
chr16_+_57023406 | 0.36 |
ENST00000262510.6
ENST00000308149.7 ENST00000436936.1 |
NLRC5
|
NLR family, CARD domain containing 5 |
chr8_-_13372395 | 0.36 |
ENST00000276297.4
ENST00000511869.1 |
DLC1
|
deleted in liver cancer 1 |
chr5_+_112073544 | 0.36 |
ENST00000257430.4
ENST00000508376.2 |
APC
|
adenomatous polyposis coli |
chr8_+_54764346 | 0.36 |
ENST00000297313.3
ENST00000344277.6 |
RGS20
|
regulator of G-protein signaling 20 |
chr8_-_103668114 | 0.36 |
ENST00000285407.6
|
KLF10
|
Kruppel-like factor 10 |
chr7_-_121944491 | 0.36 |
ENST00000331178.4
ENST00000427185.2 ENST00000442488.2 |
FEZF1
|
FEZ family zinc finger 1 |
chr3_+_151531810 | 0.36 |
ENST00000232892.7
|
AADAC
|
arylacetamide deacetylase |
chr15_+_94899183 | 0.36 |
ENST00000557742.1
|
MCTP2
|
multiple C2 domains, transmembrane 2 |
chr13_+_42846272 | 0.36 |
ENST00000025301.2
|
AKAP11
|
A kinase (PRKA) anchor protein 11 |
chr6_+_53883790 | 0.36 |
ENST00000509997.1
|
MLIP
|
muscular LMNA-interacting protein |
chr19_+_1067271 | 0.35 |
ENST00000536472.1
ENST00000590214.1 |
HMHA1
|
histocompatibility (minor) HA-1 |
chr1_+_156863470 | 0.35 |
ENST00000338302.3
ENST00000455314.1 ENST00000292357.7 |
PEAR1
|
platelet endothelial aggregation receptor 1 |
chr2_+_113885138 | 0.35 |
ENST00000409930.3
|
IL1RN
|
interleukin 1 receptor antagonist |
chr2_+_234959376 | 0.35 |
ENST00000425558.1
|
SPP2
|
secreted phosphoprotein 2, 24kDa |
chr1_+_210406121 | 0.35 |
ENST00000367012.3
|
SERTAD4
|
SERTA domain containing 4 |
chr8_-_71581377 | 0.35 |
ENST00000276590.4
ENST00000522447.1 |
LACTB2
|
lactamase, beta 2 |
chr12_+_109826524 | 0.35 |
ENST00000431443.2
|
MYO1H
|
myosin IH |
chr10_+_99609996 | 0.35 |
ENST00000370602.1
|
GOLGA7B
|
golgin A7 family, member B |
chr1_-_155270770 | 0.35 |
ENST00000392414.3
|
PKLR
|
pyruvate kinase, liver and RBC |
chr11_-_5271122 | 0.35 |
ENST00000330597.3
|
HBG1
|
hemoglobin, gamma A |
chr19_+_19174795 | 0.34 |
ENST00000318596.7
|
SLC25A42
|
solute carrier family 25, member 42 |
chr20_-_18774614 | 0.34 |
ENST00000412553.1
|
LINC00652
|
long intergenic non-protein coding RNA 652 |
chr1_-_57431679 | 0.34 |
ENST00000371237.4
ENST00000535057.1 ENST00000543257.1 |
C8B
|
complement component 8, beta polypeptide |
chr1_+_175036966 | 0.34 |
ENST00000239462.4
|
TNN
|
tenascin N |
chr5_+_139505520 | 0.34 |
ENST00000333305.3
|
IGIP
|
IgA-inducing protein |
chr11_+_7618413 | 0.34 |
ENST00000528883.1
|
PPFIBP2
|
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
chr2_+_7017796 | 0.34 |
ENST00000382040.3
|
RSAD2
|
radical S-adenosyl methionine domain containing 2 |
chr1_-_152131703 | 0.34 |
ENST00000316073.3
|
RPTN
|
repetin |
chr2_+_1417228 | 0.34 |
ENST00000382269.3
ENST00000337415.3 ENST00000345913.4 ENST00000346956.3 ENST00000349624.3 ENST00000539820.1 ENST00000329066.4 ENST00000382201.3 |
TPO
|
thyroid peroxidase |
chr19_-_42894420 | 0.34 |
ENST00000597255.1
ENST00000222032.5 |
CNFN
|
cornifelin |
chr19_-_55574538 | 0.33 |
ENST00000415061.3
|
RDH13
|
retinol dehydrogenase 13 (all-trans/9-cis) |
chr8_+_125985531 | 0.33 |
ENST00000319286.5
|
ZNF572
|
zinc finger protein 572 |
chr9_-_85882145 | 0.33 |
ENST00000328788.1
|
FRMD3
|
FERM domain containing 3 |
chr14_-_85996332 | 0.33 |
ENST00000380722.1
|
RP11-497E19.1
|
RP11-497E19.1 |
chr5_-_35938674 | 0.33 |
ENST00000397366.1
ENST00000513623.1 ENST00000514524.1 ENST00000397367.2 |
CAPSL
|
calcyphosine-like |
chr9_-_6015607 | 0.33 |
ENST00000259569.5
|
RANBP6
|
RAN binding protein 6 |
chr2_-_37068530 | 0.33 |
ENST00000593798.1
|
AC007382.1
|
Uncharacterized protein |
chr13_-_33859819 | 0.33 |
ENST00000336934.5
|
STARD13
|
StAR-related lipid transfer (START) domain containing 13 |
chr1_-_226129189 | 0.33 |
ENST00000366820.5
|
LEFTY2
|
left-right determination factor 2 |
chr1_-_145039949 | 0.33 |
ENST00000313382.9
|
PDE4DIP
|
phosphodiesterase 4D interacting protein |
chr1_+_158978768 | 0.33 |
ENST00000447473.2
|
IFI16
|
interferon, gamma-inducible protein 16 |
chr6_-_45983549 | 0.33 |
ENST00000544153.1
|
CLIC5
|
chloride intracellular channel 5 |
chr19_-_23941680 | 0.33 |
ENST00000402377.3
|
ZNF681
|
zinc finger protein 681 |
chr10_-_113943447 | 0.32 |
ENST00000369425.1
ENST00000348367.4 ENST00000423155.1 |
GPAM
|
glycerol-3-phosphate acyltransferase, mitochondrial |
chr1_+_26438289 | 0.32 |
ENST00000374271.4
ENST00000374269.1 |
PDIK1L
|
PDLIM1 interacting kinase 1 like |
chr7_+_5919458 | 0.32 |
ENST00000416608.1
|
OCM
|
oncomodulin |
chr12_-_7281469 | 0.32 |
ENST00000542370.1
ENST00000266560.3 |
RBP5
|
retinol binding protein 5, cellular |
chr17_-_20370847 | 0.32 |
ENST00000423676.3
ENST00000324290.5 |
LGALS9B
|
lectin, galactoside-binding, soluble, 9B |
chr11_-_89654935 | 0.32 |
ENST00000530311.2
|
TRIM49D1
|
tripartite motif containing 49D1 |
chr1_+_158900568 | 0.32 |
ENST00000458222.1
|
PYHIN1
|
pyrin and HIN domain family, member 1 |
chrX_-_21776281 | 0.31 |
ENST00000379494.3
|
SMPX
|
small muscle protein, X-linked |
chr16_+_88872176 | 0.31 |
ENST00000569140.1
|
CDT1
|
chromatin licensing and DNA replication factor 1 |
chr2_+_1507506 | 0.31 |
ENST00000425083.1
|
TPO
|
thyroid peroxidase |
chr16_+_50187556 | 0.31 |
ENST00000561678.1
ENST00000357464.3 |
PAPD5
|
PAP associated domain containing 5 |
chr2_+_11295624 | 0.31 |
ENST00000402361.1
ENST00000428481.1 |
PQLC3
|
PQ loop repeat containing 3 |
chr21_+_42792442 | 0.31 |
ENST00000398600.2
|
MX1
|
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
chr3_+_193853927 | 0.31 |
ENST00000232424.3
|
HES1
|
hes family bHLH transcription factor 1 |
chr16_+_12058961 | 0.31 |
ENST00000053243.1
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17 |
chr19_+_51273721 | 0.30 |
ENST00000270590.4
|
GPR32
|
G protein-coupled receptor 32 |
chr12_+_113344811 | 0.30 |
ENST00000551241.1
ENST00000553185.1 ENST00000550689.1 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr3_+_88108381 | 0.30 |
ENST00000473136.1
|
RP11-159G9.5
|
Uncharacterized protein |
chr2_+_143635067 | 0.30 |
ENST00000264170.4
|
KYNU
|
kynureninase |
chr8_-_6836156 | 0.30 |
ENST00000382679.2
|
DEFA1
|
defensin, alpha 1 |
chrX_+_49969405 | 0.30 |
ENST00000376042.1
|
CCNB3
|
cyclin B3 |
chr12_-_42983478 | 0.30 |
ENST00000345127.3
ENST00000547113.1 |
PRICKLE1
|
prickle homolog 1 (Drosophila) |
chr14_+_85996471 | 0.30 |
ENST00000330753.4
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2 |
chr6_+_159590423 | 0.30 |
ENST00000297267.9
ENST00000340366.6 |
FNDC1
|
fibronectin type III domain containing 1 |
chr20_-_45984401 | 0.30 |
ENST00000311275.7
|
ZMYND8
|
zinc finger, MYND-type containing 8 |
chr12_+_12938541 | 0.30 |
ENST00000356591.4
|
APOLD1
|
apolipoprotein L domain containing 1 |
chr11_-_119991589 | 0.30 |
ENST00000526881.1
|
TRIM29
|
tripartite motif containing 29 |
chr13_+_37006421 | 0.30 |
ENST00000255465.4
|
CCNA1
|
cyclin A1 |
chr16_+_12059050 | 0.30 |
ENST00000396495.3
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17 |
chr15_+_31196053 | 0.30 |
ENST00000561594.1
ENST00000362065.4 |
FAN1
|
FANCD2/FANCI-associated nuclease 1 |
chr17_-_30668887 | 0.29 |
ENST00000581747.1
ENST00000583334.1 ENST00000580558.1 |
C17orf75
|
chromosome 17 open reading frame 75 |
chr12_-_42877726 | 0.29 |
ENST00000548696.1
|
PRICKLE1
|
prickle homolog 1 (Drosophila) |
chr11_-_71639670 | 0.29 |
ENST00000533047.1
ENST00000529844.1 |
RP11-849H4.2
|
Putative short transient receptor potential channel 2-like protein |
chr3_+_29322803 | 0.29 |
ENST00000396583.3
ENST00000383767.2 |
RBMS3
|
RNA binding motif, single stranded interacting protein 3 |
chr14_+_85996507 | 0.29 |
ENST00000554746.1
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2 |
chr3_+_29322933 | 0.29 |
ENST00000273139.9
ENST00000383766.2 |
RBMS3
|
RNA binding motif, single stranded interacting protein 3 |
chr9_-_100459639 | 0.29 |
ENST00000375128.4
|
XPA
|
xeroderma pigmentosum, complementation group A |
chr3_-_52860850 | 0.29 |
ENST00000441637.2
|
ITIH4
|
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
chr1_-_226129083 | 0.29 |
ENST00000420304.2
|
LEFTY2
|
left-right determination factor 2 |
chr18_-_24129367 | 0.29 |
ENST00000408011.3
|
KCTD1
|
potassium channel tetramerization domain containing 1 |
chr22_+_21128167 | 0.29 |
ENST00000215727.5
|
SERPIND1
|
serpin peptidase inhibitor, clade D (heparin cofactor), member 1 |
chr1_-_236030216 | 0.29 |
ENST00000389794.3
ENST00000389793.2 |
LYST
|
lysosomal trafficking regulator |
chr17_+_1646130 | 0.29 |
ENST00000453066.1
ENST00000324015.3 ENST00000450523.2 ENST00000453723.1 ENST00000382061.4 |
SERPINF2
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 |
chr16_+_53164833 | 0.29 |
ENST00000564845.1
|
CHD9
|
chromodomain helicase DNA binding protein 9 |
chr11_+_9482551 | 0.29 |
ENST00000438144.2
ENST00000526657.1 ENST00000299606.2 ENST00000534265.1 ENST00000412390.2 |
ZNF143
|
zinc finger protein 143 |
chr2_-_68694390 | 0.29 |
ENST00000377957.3
|
FBXO48
|
F-box protein 48 |
chr2_+_204801471 | 0.29 |
ENST00000316386.6
ENST00000435193.1 |
ICOS
|
inducible T-cell co-stimulator |
chr5_-_176057518 | 0.29 |
ENST00000393693.2
|
SNCB
|
synuclein, beta |
chr14_+_21510385 | 0.29 |
ENST00000298690.4
|
RNASE7
|
ribonuclease, RNase A family, 7 |
chr1_+_63989004 | 0.29 |
ENST00000371088.4
|
EFCAB7
|
EF-hand calcium binding domain 7 |
chr4_-_175443484 | 0.29 |
ENST00000514584.1
ENST00000542498.1 ENST00000296521.7 ENST00000422112.2 ENST00000504433.1 |
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD) |
chr13_+_33160553 | 0.28 |
ENST00000315596.10
|
PDS5B
|
PDS5, regulator of cohesion maintenance, homolog B (S. cerevisiae) |
chr7_-_25268104 | 0.28 |
ENST00000222674.2
|
NPVF
|
neuropeptide VF precursor |
chr1_-_153066998 | 0.28 |
ENST00000368750.3
|
SPRR2E
|
small proline-rich protein 2E |
chr1_-_162346657 | 0.28 |
ENST00000367935.5
|
C1orf111
|
chromosome 1 open reading frame 111 |
chr7_-_71868354 | 0.28 |
ENST00000412588.1
|
CALN1
|
calneuron 1 |
chr19_+_44645731 | 0.28 |
ENST00000426739.2
|
ZNF234
|
zinc finger protein 234 |
chr7_-_142120321 | 0.28 |
ENST00000390377.1
|
TRBV7-7
|
T cell receptor beta variable 7-7 |
chr13_+_37006398 | 0.28 |
ENST00000418263.1
|
CCNA1
|
cyclin A1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.8 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
0.2 | 0.5 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.2 | 0.5 | GO:2001248 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
0.2 | 0.5 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.2 | 1.0 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.2 | 0.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 0.6 | GO:0009644 | response to high light intensity(GO:0009644) |
0.2 | 0.5 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
0.1 | 0.6 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.1 | 0.4 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.1 | 0.4 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.1 | 0.6 | GO:1905066 | regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) |
0.1 | 0.8 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 0.4 | GO:0008050 | female courtship behavior(GO:0008050) |
0.1 | 0.7 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.1 | 0.4 | GO:0035602 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) |
0.1 | 0.4 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.1 | 0.4 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.1 | 0.6 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.1 | 0.5 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
0.1 | 0.3 | GO:0080121 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
0.1 | 0.3 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.1 | 0.3 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.1 | 0.8 | GO:0061589 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.1 | 0.7 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.1 | 0.3 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
0.1 | 0.3 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) negative regulation of DNA catabolic process(GO:1903625) |
0.1 | 0.4 | GO:2001178 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.1 | 0.4 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.1 | 0.5 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.1 | 0.3 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.1 | 0.5 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.1 | 0.4 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
0.1 | 0.4 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
0.1 | 0.4 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
0.1 | 0.8 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.1 | 0.3 | GO:0002585 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) detection of peptidoglycan(GO:0032499) |
0.1 | 0.7 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 1.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.4 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
0.1 | 0.4 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.1 | 0.7 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.1 | 0.5 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.1 | 0.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.1 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.1 | 0.1 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.3 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.1 | 0.3 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.1 | 0.3 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.1 | 0.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.1 | 0.3 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) |
0.1 | 0.1 | GO:1902304 | positive regulation of potassium ion export(GO:1902304) |
0.1 | 0.2 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
0.1 | 0.6 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.1 | 0.2 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.1 | 0.2 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.2 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
0.1 | 0.3 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.1 | 0.7 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.1 | 0.4 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.2 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.6 | GO:0051459 | regulation of corticotropin secretion(GO:0051459) |
0.1 | 0.2 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.1 | 0.2 | GO:0098923 | retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) trans-synaptic signaling by trans-synaptic complex(GO:0099545) |
0.1 | 0.2 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.1 | 0.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 0.2 | GO:1990569 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
0.1 | 0.1 | GO:0061317 | canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) |
0.1 | 0.3 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 0.4 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.3 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
0.1 | 0.3 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
0.1 | 0.2 | GO:0042214 | terpene metabolic process(GO:0042214) |
0.1 | 0.4 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.1 | 0.3 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.4 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 | 0.2 | GO:1903568 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
0.1 | 0.2 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.1 | 0.1 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.1 | 0.1 | GO:0071484 | cellular response to light intensity(GO:0071484) |
0.1 | 0.3 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.6 | GO:0043634 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
0.1 | 0.1 | GO:0046102 | adenosine catabolic process(GO:0006154) hypoxanthine salvage(GO:0043103) inosine metabolic process(GO:0046102) inosine biosynthetic process(GO:0046103) |
0.1 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.2 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.2 | GO:0003193 | pulmonary valve formation(GO:0003193) regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) foramen ovale closure(GO:0035922) regulation of bundle of His cell action potential(GO:0098905) |
0.1 | 0.2 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 0.2 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
0.1 | 0.4 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.1 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
0.1 | 0.4 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.1 | 0.3 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.5 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.4 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.1 | 0.3 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
0.1 | 0.5 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.1 | 1.0 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.1 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.1 | 0.1 | GO:2000866 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
0.1 | 0.2 | GO:0007538 | primary sex determination(GO:0007538) |
0.1 | 0.3 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.3 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
0.1 | 0.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.1 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.1 | 1.5 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.3 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.2 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.1 | 0.3 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 1.3 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 0.2 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.1 | 0.2 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.1 | 0.3 | GO:1901558 | response to metformin(GO:1901558) |
0.1 | 0.2 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
0.1 | 0.1 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.1 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.1 | 0.3 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.1 | 0.2 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.1 | 0.6 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 0.1 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.1 | 0.1 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.1 | 0.4 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.1 | 0.3 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.0 | 0.4 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.0 | 0.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.1 | GO:1901207 | regulation of heart looping(GO:1901207) |
0.0 | 0.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 | 0.0 | GO:0010157 | response to chlorate(GO:0010157) |
0.0 | 0.2 | GO:1900827 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.0 | 0.2 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.0 | 0.2 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.2 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.0 | 0.3 | GO:0097319 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.0 | 0.5 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.0 | 0.1 | GO:0010949 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
0.0 | 0.6 | GO:0042048 | olfactory behavior(GO:0042048) |
0.0 | 0.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.3 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 1.6 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.2 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) |
0.0 | 0.1 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.3 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.0 | 0.0 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
0.0 | 0.2 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.0 | 0.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) N-terminal protein palmitoylation(GO:0006500) |
0.0 | 0.1 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
0.0 | 0.1 | GO:1900158 | regulation of bone mineralization involved in bone maturation(GO:1900157) negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.0 | 0.2 | GO:1900247 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.0 | 0.1 | GO:0061009 | common bile duct development(GO:0061009) |
0.0 | 0.1 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
0.0 | 0.2 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) uroporphyrinogen III metabolic process(GO:0046502) |
0.0 | 0.4 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.0 | 0.1 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.0 | 0.1 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.0 | 0.1 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.0 | 0.2 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
0.0 | 4.9 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.0 | 0.0 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
0.0 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.2 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
0.0 | 0.2 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.0 | 0.5 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.3 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.1 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
0.0 | 0.1 | GO:0072204 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.0 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.0 | 0.1 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.0 | 0.2 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.0 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.2 | GO:0036309 | protein localization to M-band(GO:0036309) |
0.0 | 0.2 | GO:0045959 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
0.0 | 0.2 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.0 | 0.2 | GO:0048698 | regulation of collateral sprouting in absence of injury(GO:0048696) negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.0 | 0.3 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.2 | GO:0019566 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
0.0 | 0.1 | GO:1902567 | negative regulation of eosinophil activation(GO:1902567) |
0.0 | 0.1 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
0.0 | 0.1 | GO:0039019 | regulation of polarized epithelial cell differentiation(GO:0030860) pronephric nephron development(GO:0039019) |
0.0 | 0.7 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.3 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.0 | 0.0 | GO:1903413 | cellular response to bile acid(GO:1903413) |
0.0 | 0.2 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.0 | 0.5 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.0 | 0.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.0 | GO:0046959 | habituation(GO:0046959) |
0.0 | 0.1 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.0 | 0.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.2 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.0 | 0.1 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.1 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.0 | 0.1 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.0 | 0.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.0 | 0.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.1 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
0.0 | 0.1 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.0 | 0.1 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
0.0 | 0.1 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.0 | 0.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.1 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) positive regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000340) |
0.0 | 0.1 | GO:0034445 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
0.0 | 0.0 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.0 | 0.1 | GO:0039513 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
0.0 | 0.7 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.0 | 0.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.0 | 0.2 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.0 | 0.1 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.0 | 0.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.1 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.0 | 0.1 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
0.0 | 0.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.2 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.0 | 0.1 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.0 | 0.2 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.3 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.2 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.0 | 0.1 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.0 | 0.1 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.0 | 0.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.0 | 0.1 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
0.0 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.1 | GO:1990180 | mitochondrial tRNA 3'-end processing(GO:1990180) |
0.0 | 0.1 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.0 | 0.1 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.0 | 0.2 | GO:0010731 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
0.0 | 0.2 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.0 | 0.1 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.0 | 0.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.0 | 0.3 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.4 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.1 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
0.0 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.1 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.0 | 0.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.4 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.0 | 0.5 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.2 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.0 | 0.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.1 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
0.0 | 0.3 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.1 | GO:0009386 | translational attenuation(GO:0009386) |
0.0 | 0.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.3 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.0 | 0.1 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.0 | 0.1 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.0 | 0.1 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.0 | 0.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.1 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.0 | 0.2 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.0 | 0.4 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.1 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
0.0 | 0.1 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
0.0 | 0.4 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.0 | 0.1 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.0 | 0.2 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
0.0 | 0.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.1 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.0 | 0.1 | GO:0002501 | peptide antigen assembly with MHC protein complex(GO:0002501) |
0.0 | 0.2 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.0 | 0.3 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 0.2 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.1 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.0 | 0.1 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.0 | 0.1 | GO:1900005 | positive regulation of serine-type endopeptidase activity(GO:1900005) positive regulation of serine-type peptidase activity(GO:1902573) |
0.0 | 0.1 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.0 | 0.3 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.0 | 0.1 | GO:0019085 | early viral transcription(GO:0019085) |
0.0 | 0.2 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.0 | 0.2 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.0 | 0.2 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.3 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.1 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.0 | 0.2 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.0 | 0.2 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
0.0 | 0.2 | GO:0042723 | thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.1 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
0.0 | 0.1 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.0 | 0.1 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
0.0 | 0.3 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.0 | 0.2 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
0.0 | 0.5 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) |
0.0 | 0.4 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.0 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.0 | 0.1 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.0 | 1.9 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.5 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.0 | 0.1 | GO:0099538 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.2 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.0 | 0.2 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.0 | 0.4 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
0.0 | 0.1 | GO:0006738 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
0.0 | 0.1 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.3 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 | 0.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.1 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.0 | 0.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.1 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.0 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.0 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) |
0.0 | 0.2 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 0.1 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.0 | 0.1 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) |
0.0 | 1.0 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.0 | 0.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.0 | 0.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.0 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.0 | 0.1 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.0 | 0.1 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.0 | 0.1 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
0.0 | 0.1 | GO:0061216 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) mesodermal cell fate determination(GO:0007500) intermediate mesoderm development(GO:0048389) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) pattern specification involved in mesonephros development(GO:0061227) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in kidney development(GO:0072098) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter urothelium development(GO:0072190) ureter epithelial cell differentiation(GO:0072192) ureter morphogenesis(GO:0072197) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901963) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
0.0 | 0.0 | GO:1902731 | negative regulation of chondrocyte proliferation(GO:1902731) |
0.0 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.1 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.0 | 0.1 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.0 | 0.1 | GO:1902159 | regulation of cyclic nucleotide-gated ion channel activity(GO:1902159) positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
0.0 | 0.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.0 | 0.1 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.0 | 0.1 | GO:0018874 | benzoate metabolic process(GO:0018874) |
0.0 | 0.4 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.6 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.3 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.0 | 0.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.0 | 0.0 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.1 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
0.0 | 0.1 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.0 | 0.0 | GO:0022605 | oogenesis stage(GO:0022605) |
0.0 | 0.3 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 0.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.2 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.0 | 0.1 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.0 | 0.2 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.0 | 0.0 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.0 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.0 | 0.1 | GO:0061525 | hindgut development(GO:0061525) |
0.0 | 0.0 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.0 | 0.1 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.0 | 0.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.1 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.0 | 0.0 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.0 | 0.2 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.0 | 0.1 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.0 | 0.1 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) |
0.0 | 0.0 | GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
0.0 | 0.1 | GO:0060356 | leucine import(GO:0060356) |
0.0 | 0.0 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.8 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.0 | GO:0048880 | sensory system development(GO:0048880) |
0.0 | 0.1 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
0.0 | 0.3 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.0 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.0 | 0.0 | GO:0099553 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.0 | 0.1 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.0 | GO:0033076 | isoquinoline alkaloid metabolic process(GO:0033076) phytoalexin metabolic process(GO:0052314) |
0.0 | 0.2 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
0.0 | 0.1 | GO:0034239 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
0.0 | 0.1 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.0 | 0.5 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.0 | 0.1 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
0.0 | 0.1 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.1 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.0 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.0 | 0.6 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.1 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.0 | 0.4 | GO:0001562 | response to protozoan(GO:0001562) |
0.0 | 0.2 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.0 | 0.1 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 0.3 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.0 | 0.3 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.0 | 0.1 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.0 | 0.2 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.0 | 0.1 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.0 | 0.2 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.0 | 0.1 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.0 | 0.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.1 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.0 | 0.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.0 | 0.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.1 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
0.0 | 0.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.0 | GO:2000410 | T-helper 1 cell activation(GO:0035711) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.1 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.0 | 0.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.0 | 0.3 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.0 | 0.2 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.0 | 0.1 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.0 | 0.0 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.0 | 0.1 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.0 | 0.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.1 | GO:0050758 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) |
0.0 | 0.0 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.0 | 0.1 | GO:1990564 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.1 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.0 | 0.4 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 0.1 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
0.0 | 0.1 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.0 | 0.1 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.0 | 0.2 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.0 | 0.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
0.0 | 0.3 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.1 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
0.0 | 0.0 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.0 | 0.6 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 0.1 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.0 | 0.2 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.1 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.0 | 0.1 | GO:1902896 | terminal web assembly(GO:1902896) |
0.0 | 0.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.0 | GO:0042710 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.1 | GO:0002818 | intracellular defense response(GO:0002818) |
0.0 | 0.1 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.0 | 0.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.1 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.0 | GO:0042335 | cuticle development(GO:0042335) |
0.0 | 0.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.0 | 0.1 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.0 | 0.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.4 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.3 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.0 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
0.0 | 0.1 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.0 | 0.1 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.0 | 0.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 0.0 | GO:0042323 | regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) negative regulation of mucus secretion(GO:0070256) |
0.0 | 0.1 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.0 | GO:0003032 | detection of oxygen(GO:0003032) |
0.0 | 0.0 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.0 | 0.2 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.0 | 0.1 | GO:0042436 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.0 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.0 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) double-strand break repair involved in meiotic recombination(GO:1990918) |
0.0 | 0.0 | GO:0035977 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.0 | 0.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.2 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.6 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.1 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.1 | GO:0090493 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.0 | 0.3 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 0.1 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
0.0 | 0.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.4 | GO:0072663 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.0 | 0.5 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.0 | 0.0 | GO:0072221 | distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) |
0.0 | 0.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.0 | 0.0 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.0 | 0.0 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.0 | 0.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.0 | 0.2 | GO:0097369 | sodium ion import(GO:0097369) |
0.0 | 0.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.0 | 0.2 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.1 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.0 | 0.2 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.0 | 0.1 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.0 | 0.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 0.1 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.0 | 0.1 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.0 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.0 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.0 | 0.1 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.0 | 0.1 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.4 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
0.0 | 0.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.1 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.0 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.0 | 0.1 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.4 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.0 | 0.0 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.0 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.0 | 0.1 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.0 | 0.0 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
0.0 | 0.3 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.0 | 0.4 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.0 | 0.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.6 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.0 | 0.0 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
0.0 | 0.3 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.0 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.0 | 0.0 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
0.0 | 0.3 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.0 | GO:1902943 | regulation of voltage-gated chloride channel activity(GO:1902941) positive regulation of voltage-gated chloride channel activity(GO:1902943) positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.0 | 0.1 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.0 | 0.2 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.0 | 0.1 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.0 | 0.0 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.1 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.0 | 0.0 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.1 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.0 | 0.1 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.0 | 0.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.1 | GO:0035864 | response to potassium ion(GO:0035864) |
0.0 | 0.1 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.0 | 0.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.0 | 2.4 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.3 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 0.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.1 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.0 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.0 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
0.0 | 0.0 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.0 | 0.1 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.0 | 0.0 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.0 | 0.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.0 | GO:0097032 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.0 | 0.2 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.0 | 0.0 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.0 | 0.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 0.0 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.0 | 0.0 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.3 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.1 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.0 | 0.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.5 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
0.0 | 0.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.2 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.0 | 0.1 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.0 | 0.1 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.0 | 0.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.0 | 0.0 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.0 | 0.2 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.0 | 0.1 | GO:0030047 | actin modification(GO:0030047) |
0.0 | 0.4 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.0 | 0.0 | GO:0071899 | transcriptional activation by promoter-enhancer looping(GO:0071733) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.0 | 0.0 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.0 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.0 | 0.0 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.0 | 0.1 | GO:0097484 | dendrite extension(GO:0097484) |
0.0 | 0.3 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.0 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.0 | 0.1 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.0 | 0.1 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.0 | 0.0 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.0 | 0.1 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.0 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.0 | 0.0 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.0 | GO:0009216 | purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) adenosine biosynthetic process(GO:0046086) |
0.0 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.3 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.0 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.0 | 0.0 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.0 | 0.1 | GO:0000732 | strand displacement(GO:0000732) |
0.0 | 0.0 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.0 | 0.1 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.0 | 0.1 | GO:0006971 | hypotonic response(GO:0006971) cellular hypotonic response(GO:0071476) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.5 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.1 | 0.2 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.1 | 0.5 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.6 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 0.3 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.1 | 0.3 | GO:0097196 | Shu complex(GO:0097196) |
0.1 | 0.2 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
0.1 | 0.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 0.5 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.2 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
0.1 | 0.1 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
0.1 | 0.2 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.1 | 0.2 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.1 | 0.2 | GO:0019034 | viral replication complex(GO:0019034) |
0.1 | 0.2 | GO:0097679 | other organism cytoplasm(GO:0097679) |
0.1 | 0.3 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.5 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.3 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 0.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.3 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.1 | GO:0044609 | DBIRD complex(GO:0044609) |
0.0 | 0.2 | GO:0031673 | H zone(GO:0031673) |
0.0 | 0.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 0.1 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
0.0 | 0.8 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 0.3 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.1 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 0.1 | GO:0043291 | RAVE complex(GO:0043291) |
0.0 | 0.2 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.0 | 1.0 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 0.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.2 | GO:0036398 | TCR signalosome(GO:0036398) |
0.0 | 0.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.3 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 0.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.2 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.0 | 0.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.0 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.1 | GO:1990742 | microvesicle(GO:1990742) |
0.0 | 2.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.1 | GO:0034657 | GID complex(GO:0034657) |
0.0 | 0.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 0.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.1 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.0 | 0.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.2 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.1 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
0.0 | 0.1 | GO:0000938 | GARP complex(GO:0000938) |
0.0 | 0.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.1 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.0 | 0.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.1 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
0.0 | 0.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.0 | 0.3 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.5 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 0.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 0.1 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
0.0 | 0.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.2 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.0 | 0.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.3 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.2 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.0 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.1 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
0.0 | 0.2 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.0 | 0.0 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 0.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.0 | 0.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 0.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.0 | 0.3 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.0 | 0.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.0 | 0.1 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.0 | 0.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.3 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.1 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.4 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.3 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.7 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.1 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.0 | 0.2 | GO:0051286 | cell tip(GO:0051286) |
0.0 | 0.0 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.0 | 0.1 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.3 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.1 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.0 | 0.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.1 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.0 | 0.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.0 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.0 | 0.1 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.0 | 0.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 1.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.2 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 1.0 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.0 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.0 | 1.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.2 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.0 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.1 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.1 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.8 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.0 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.0 | 0.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 1.3 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.1 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.0 | 0.2 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.0 | 0.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.1 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
0.0 | 0.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.4 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.2 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.2 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.0 | 0.0 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
0.0 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 1.2 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 1.5 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.5 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.0 | 0.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 0.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.0 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.0 | 0.1 | GO:0097433 | dense body(GO:0097433) |
0.0 | 0.6 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.0 | 0.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.0 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.6 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 1.2 | GO:0043204 | perikaryon(GO:0043204) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 3.7 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.3 | 0.9 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.2 | 1.4 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.2 | 0.5 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.2 | 0.5 | GO:0070336 | flap-structured DNA binding(GO:0070336) |
0.2 | 0.5 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.2 | 0.5 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.1 | 0.4 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.1 | 0.5 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.1 | 0.4 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
0.1 | 0.5 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.1 | 0.6 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 0.4 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.1 | 0.5 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
0.1 | 0.5 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.1 | 0.3 | GO:0080122 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.1 | 0.3 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.1 | 0.3 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
0.1 | 0.5 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 0.3 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
0.1 | 0.4 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.1 | 0.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.4 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.3 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.1 | 0.6 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.3 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.1 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 1.4 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.6 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.1 | 0.2 | GO:0047025 | NAD(P)H dehydrogenase (quinone) activity(GO:0003955) 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
0.1 | 0.2 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
0.1 | 0.3 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.1 | 1.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.2 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.1 | 0.4 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 0.3 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.1 | 0.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.4 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 0.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 0.2 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.1 | 0.5 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.2 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
0.1 | 0.5 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.2 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 1.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.2 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.1 | 0.1 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.1 | 0.2 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.1 | 0.5 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.3 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
0.1 | 0.2 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.1 | 0.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.3 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 0.2 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.3 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.1 | 0.2 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 0.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.2 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
0.1 | 0.2 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 0.4 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.3 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.6 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.5 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.2 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.3 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.0 | 0.3 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.0 | 0.2 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.2 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
0.0 | 0.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.1 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.0 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.3 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 0.1 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.9 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.5 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.0 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.0 | 0.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.2 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
0.0 | 0.2 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
0.0 | 0.6 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.1 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
0.0 | 0.1 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.0 | 0.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.1 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
0.0 | 0.2 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.0 | 0.2 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
0.0 | 0.2 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.0 | 0.3 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.4 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.0 | 0.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 0.5 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.0 | 0.1 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.0 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 0.6 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.2 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.7 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.2 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.0 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.3 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.2 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.0 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 0.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.0 | 0.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.1 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.0 | 0.2 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.0 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.1 | GO:0004040 | amidase activity(GO:0004040) |
0.0 | 0.2 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.0 | 0.1 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
0.0 | 0.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.4 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.1 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
0.0 | 0.1 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
0.0 | 0.3 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.4 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.6 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.4 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.4 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.0 | 0.1 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.0 | 0.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.1 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.0 | 0.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.2 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.0 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.0 | 0.1 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.0 | 0.1 | GO:0008431 | vitamin E binding(GO:0008431) |
0.0 | 0.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.0 | 0.1 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.0 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.0 | 0.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.7 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.1 | GO:0061598 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
0.0 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 0.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.1 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.0 | 0.1 | GO:0031780 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
0.0 | 0.5 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.1 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.0 | 0.4 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.1 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.0 | 0.2 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.2 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.0 | 0.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.1 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
0.0 | 0.1 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
0.0 | 0.1 | GO:0035501 | MH1 domain binding(GO:0035501) |
0.0 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.0 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.1 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.0 | 0.4 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.1 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.0 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.1 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.0 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.2 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 0.0 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.1 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.0 | 0.4 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.1 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.0 | 0.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.0 | 0.2 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.0 | 0.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.1 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
0.0 | 0.1 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.2 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.0 | 0.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.1 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.1 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.0 | 0.1 | GO:0047708 | biotinidase activity(GO:0047708) |
0.0 | 0.3 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.1 | GO:0052840 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.0 | 0.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.0 | 0.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.1 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.0 | 0.1 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.0 | 0.0 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.4 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.1 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.5 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.1 | GO:0004673 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
0.0 | 0.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 0.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.1 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.0 | 0.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.6 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.1 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.0 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.2 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.0 | 0.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.1 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.1 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 1.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.1 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.0 | 0.2 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 0.1 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.0 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.0 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 0.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.0 | 0.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.0 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.0 | 0.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 0.1 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.0 | 0.1 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.0 | 0.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.0 | 0.1 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.0 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.0 | GO:0031403 | pyridoxal kinase activity(GO:0008478) lithium ion binding(GO:0031403) |
0.0 | 0.1 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.1 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 2.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.1 | GO:0050610 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.0 | 0.0 | GO:0070538 | oleic acid binding(GO:0070538) |
0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.0 | 0.1 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.0 | 0.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.1 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 0.1 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.4 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.1 | GO:0008948 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
0.0 | 0.0 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.0 | 0.3 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.0 | 0.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.0 | 0.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.1 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.0 | 0.0 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
0.0 | 0.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.0 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.0 | 0.3 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 0.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.0 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.0 | 0.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.0 | 0.0 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.0 | 0.0 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.3 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.1 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.0 | 0.1 | GO:0015141 | citrate transmembrane transporter activity(GO:0015137) succinate transmembrane transporter activity(GO:0015141) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.1 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.0 | 0.1 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.0 | 0.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.4 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.1 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.0 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.0 | 0.3 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.0 | 0.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.0 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.0 | 0.0 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.0 | 0.1 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.0 | 0.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.3 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 1.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 2.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 1.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 1.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.1 | REACTOME ADAPTIVE IMMUNE SYSTEM | Genes involved in Adaptive Immune System |
0.0 | 0.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 1.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 1.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 1.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.7 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 1.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.0 | 0.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 0.8 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.3 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.5 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.0 | 0.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 1.0 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.4 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.0 | 0.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.5 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.5 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.7 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.0 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
0.0 | 0.1 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 0.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |